COMPANY PROFILE

Suono Bio

Explore full profile

A next-generation therapeutics platform

Foxborough, United StatesFounded 2017Biotech & Life Sciences

Valuation $50–100M Last recorded · 2021

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Suono Bio

Suono Bio operates in the biotechnology sector, focusing on the development and application of an advanced ultrasound platform for drug delivery. The company serves pharmaceutical companies and research institutions by providing a method to deliver therapeutic molecules directly into cells with high precision and speed. Suono Bio's technology is particularly effective for delivering complex and delicate molecules, such as nucleic acids, which are traditionally challenging to administer. The business model revolves around partnerships and licensing agreements with pharmaceutical firms, generating revenue through collaborative research, development contracts, and licensing fees. The market for Suono Bio's services includes the broader pharmaceutical and biotech industries, particularly those involved in the development of new therapies for previously undruggable targets. The company's innovative approach aims to enhance the efficacy and safety of therapeutic treatments, potentially transforming the landscape of drug delivery.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2017
Headquarters: Foxborough, United States
Employees: 3
Open positions: None listed
Dealroom signal: 63.6/100
Industry: Health
Sub-industry: BioTechnology, Health Platform
Sector: Biotech & Life Sciences, Biotechnology, Precision Medicine, Spinout, Biotech and Pharma, DT and LS, science-based
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

7 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Jul 2021	$8.5M	$34M	Mizuho Securities · Taiwania Capital · Axil Capital	—
SERIES AEquity / VC	Mar 2021	$8.5M	$34M	Axil Capital · Gutbrain Ventures · Mizuho Securities	—

Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

Suono Bio website traffic

Latest recorded traffic for Suono Bio is 780 monthly website visits, down 29.1% over the last three months. Suono Bio's team grew 0% over the past year.

Latest monthly visits780 3-month web change-29.1% 1-year team growth0%

Monthly website visitsOct 2017–Jan 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
CUCulminationRevolutionizing healthcare with cutting-edge insights and discoveries	St. George, United States	Operational	29	$10M	$40M
PHPhenomicshealthAn Artificial Intelligence-Powered Patient-Focused Precision Medicine company	Plymouth, United States	Operational
ATAthos therapeuticsPioneering the Development of Artificial Intelligence-based Precision Therapeutics for Chronic Inflammatory Diseases	Torrance, United States	Operational
EVevidnetProvides evidence-based medicine to patients	Seoul, South Korea	Operational
CTCertis TherapeuticsDeveloped minimally invasive therapy solutions based on real-time MRI guidance	Pessac, France	Operational
ANAntegenesGenetic tests for personalized cancer risk prevention	Tartu, Estonia	Operational
GAGLX AnalytixBringing personalized medicine to your health care	Copenhagen, Denmark	Operational
OTOdyssey TherapeuticsBuilding a machine learning-based platform to develop novel therapeutics focusing on cancer and autoimmune diseases	Boston, United States	Operational